잠시만 기다려 주세요. 로딩중입니다.

The role of natural killer cells in Parkinson’s disease

Experimental & Molecular Medicine 2020년 52권 9호 p.23 ~ 23
Earls Rachael H., 이재경,
소속 상세정보
 ( Earls Rachael H. ) - University of Georgia College of Veterinary Medicine Department of Physiology and Pharmacology
이재경 ( Lee Jae-Kyung ) - University of Georgia College of Veterinary Medicine Department of Physiology and Pharmacology

Abstract


Numerous lines of evidence indicate an association between sustained inflammation and Parkinson’s disease, but whether increased inflammation is a cause or consequence of Parkinson’s disease remains highly contested. Extensive efforts have been made to characterize microglial function in Parkinson’s disease, but the role of peripheral immune cells is less understood. Natural killer cells are innate effector lymphocytes that primarily target and kill malignant cells. Recent scientific discoveries have unveiled numerous novel functions of natural killer cells, such as resolving inflammation, forming immunological memory, and modulating antigen-presenting cell function. Furthermore, natural killer cells are capable of homing to the central nervous system in neurological disorders that exhibit exacerbated inflammation and inhibit hyperactivated microglia. Recently, a study demonstrated that natural killer cells scavenge alpha-synuclein aggregates, the primary component of Lewy bodies, and systemic depletion of natural killer cells results in exacerbated neuropathology in a mouse model of alpha-synucleinopathy, making them a highly relevant cell type in Parkinson’s disease. However, the exact role of natural killer cells in Parkinson’s disease remains elusive. In this review, we introduce the systemic inflammatory process seen in Parkinson’s disease, with a particular focus on the direct and indirect modulatory capacity of natural killer cells in the context of Parkinson’s disease.

키워드

Neuroimmunology

원문 및 링크아웃 정보

등재저널 정보